Search
for
Sort by
Research 31–60 of 56
- Unmet Medical Needs in Chronic, Non-communicable Inflammatory Skin Diseases
- Medicinal Chemistry of Drugs with <i>N</i>-Oxide Functionalities
- Patient’s experience with subcutaneous and oral methotrexate for the treatment of rheumatoid arthritis
- Social media for arthritis-related comparative effectiveness and safety research and the impact of direct-to-consumer advertising
- Hidradenitis Suppurativa and Comorbid Disorder Biomarkers, Druggable Genes, New Drugs and Drug Repurposing—A Molecular Meta-Analysis
- Drug repurposing of cyclin-dependent kinase inhibitors for neutrophilic acute respiratory distress syndrome and psoriasis
- The Tumor Necrosis Factor-α Level in Platelet-Rich Plasma Might Be Associated with Treatment Outcome in Patients with Interstitial Cystitis/Bladder Pain Syndrome or Recurrent Urinary Tract Infection
- Management of folliculitis decalvans: The EADV task force on hair diseases position statement
- Cannabinoid Compounds as a Pharmacotherapeutic Option for the Treatment of Non-Cancer Skin Diseases
- Perifolliculitis capitis abscedens et suffodiens treatment with tumor necrosis factor inhibitors and baricitinib: A case report and literature review
- Adverse Reactions to Biologic Medications Used in Allergy and Immunology Diseases
- Biologics and Small Molecules for Inflammatory Nail Disorders: A Narrative Review
- Screening of dermatology drugs for aberrant use‐patterns: An application of epidemiologic estimates and measures of inequality in drug use
- Annual Convention in the Time of COVID
- Treatment approaches and therapeutic outcomes in patients with folliculitis decalvans: A single-center, retrospective case series
- Molecular cytokine-dependent mechanisms of periodontitis pathogenesis and the potential for pharmacological IL-1 modulation in disease treatment
- Diagnostic Challenges and Treatment Strategies in Neutrophilic Cicatricial Alopecias: A Narrative Review from Conventional Therapies to New Therapeutic Targets
- Dissecting Cellulitis of the Scalp: Linking Pathogenesis to Therapy
- JAK-Inhibitors Beyond the Label: Emerging Applications in Dermatology
- Treatment Survival and Reasons for Discontinuation in Patients with Recalcitrant Folliculitis Decalvans
- SARS‐COV2 Vaccination and Hidradenitis Suppurativa: Role of Vaccination in Disease Activity
- Drug-Induced Hair Loss: Analysis of the Food and Drug Administration’s Adverse Events Reporting System Database
- Chemical Synthetic Disease Modifying Drugs (csDMARD) Used forRheumatoid Arthritis
- Application of the waiting time distribution in a nationwide screening of real‐world dermatology drug utilization for aberrant use patterns
- IL-33 Contributes to the Pathological Changes of Hair Follicles in Psoriasis: A Potential Target for Psoriatic Alopecia
- Association of Alopecia Areata With Attention-Deficit/Hyperactivity Disorder Stimulant Medication: A Case-Control Study
- Psoriatic Skin Lesions Induced by Certolizumab Pegol
- Paradoxical Skin Reaction to Certolizumab, an Overlap of Pyoderma Gangrenosum and Psoriasis in a Young Woman Treated for Ankylosing Spondylitis: Case Report with Literature Review
- Psoriatic Alopecia and Paradoxical Psoriasis Induced by Adalimumab Successfully Treated with Certolizumab: Clinical, Trichoscopic, and in vivo Reflectance Confocal Microscopy Features
- Alopecia induced by tumour necrosis factor-alpha antagonists: description of 52 cases and disproportionality analysis in a nationwide pharmacovigilance database